Advertisement

Early Recovery of Striatal Dopamine Uptake in Rats with Unilateral Nigro-Striatal Lesion Following Treatment with Monosialoganglioside

  • Maurizio Raiteri
  • Paola Versace
  • Mario Marchi
Part of the FIDIA Research Series book series (FIDIA, volume 6)

Abstract

Evidence is accumulating that the central nervous system of the adult animal is capable of morphological, biochemical and functional recovery following injury (Cot-man et al., 1981; Freed et al., 1985). Gangliosides, which are normally present in neuronal membranes, seem to play a role in the events related to neuronal plasticity. In fact, the administration of purified gangliosides was shown to enhance the recovery processes after lesioning of the central and peripheral nervous system (Rapport and Gorio, 1981; Toffano et al., 1983; Agnati et al., 1983; Sabel et al., 1984a; Jonsson et al., 1984). It has been recently reported that after unilateral hemitransection of the nigro-striatal pathway in the rat, long-term treatment with GMI ganglioside stimulated the dopaminergic reinnervation in the striatum by enhancing the collateral sprouting of the nigro-striatal dopaminergic neurons (Toffano et al., 1983; 1984a; 1984b; Aldinio et al., 1984; Sabel et al., 1984b). The question arises whether the terminals of the nerve fibers regenerating under the action of gangliosides possess all the presynaptic characteristics of a “normal” striatal dopaminergic nerve terminal. In the present investigation we have studied the effect of repeated administration of monosialoganglioside inner ester on 3H-DA uptake activity in striatal synaptosomes after unilateral hemitransection of the nigro-striatal pathway.

Keywords

Tyrosine Hydroxylase Lesion Side Saline Treated Animal Tyrosine Hydroxylase Activity Striatal Synaptosome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

DMI

desmethylimipramine

DA

dopamine

DOPA

dihydroxyphenylanine.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agnati LF, Fuxe K, Calza L, Benfenati F, Cavicchioli L, Toffano G, Goldstein M (1983) Gangliosides increase the survival of lesioned nigra dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. Acta Physiol Scand 119: 347–363.PubMedCrossRefGoogle Scholar
  2. Aldinio C, Valenti G, Savoini G, Kirschner G, Agnati LF, Toffano G (1984) Monosialoganglioside internal ester stimulates the dopaminergic reinnervation of the striatum after unilateral hemitransection in rats. Int J Dev Neurosci 2: 267–275.CrossRefGoogle Scholar
  3. Borzeix MG (1984) Drugs effect in an experimental stroke resulting from a transient cerebral oligemia. In: The need for treatment for stroke, Alzheimer’s disease and abnormal brain aging. MEM-G.M.D. vol. 1, n. 3; pp. 44.Google Scholar
  4. Cotman CW, Neito-Sampedro N, Harris EW (1981) Synapse replacement in the nervous system of adult vertebrate. Physiol Rev 71: 684–784.Google Scholar
  5. Freed WJ, de Medinaceli L, Wyatt RJ (1985) Promoting functional plasticity in the damaged nervous system. Science 227: 1544–1552.PubMedCrossRefGoogle Scholar
  6. Gray EG, Whittaker VP (1962) The isolation of nerve endings from brain: an electron microscope study of cell fragments derived by homogenization and centrifugation. J Anat 96: 79–87.PubMedGoogle Scholar
  7. Jonsson G, Gorio A, Hallman H, Janigro D, Kojima H, Zanoni R (1984) Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain. Dev Brain Res 16: 171.CrossRefGoogle Scholar
  8. Lauder JM (1983) Hormonal and humoral influences on brain development. Psychoneuroendocrinol 8: 121.CrossRefGoogle Scholar
  9. Rapport MM, Gorio A (1981) Gangliosides in neurological and neuromuscular function, development and repair. Raven Press, New York.Google Scholar
  10. Sabel BA, Slavin MD, Stein DG (1984a) GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage. Science 225: 340–342.PubMedCrossRefGoogle Scholar
  11. Sabel BA, Dunbar GL, Stein DG (1984b) Gangliosides minimize behavioral deficits and enhance structural repair after brain injury. J Neurosci Res 12: 429–443.PubMedCrossRefGoogle Scholar
  12. Toffano G, Savoini G, Moroni F, Lombardi G, Calza L, Agnati FL (1983) GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system. Brain Res 261: 163–166.PubMedCrossRefGoogle Scholar
  13. Toffano G, Savoini G, Moroni F, Lombardi G, Calza L, Agnati LF (1984a) Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat. Brain Res 296: 233–239.PubMedCrossRefGoogle Scholar
  14. Toffano G, Savoini G, Aporti F, Calzolari S, Consolazione A, Maura G, Marchi M, Raiteri M, Agnati LF (1984b) The functional recovery of damaged brain: the effect of GM1 monosialoganglioside. J Neurosci Res 12: 397–408.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • Maurizio Raiteri
    • 1
  • Paola Versace
    • 1
  • Mario Marchi
    • 1
  1. 1.Istituto di Farmacologia e FarmacognosiaUniversità di GenovaGenovaItaly

Personalised recommendations